- Deciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum
- Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences
- Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2023 Financial Results
- Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call and Webcast on February 6, 2024
- Deciphera Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
More ▼
Key statistics
As of last trade Deciphera Pharmaceuticals Inc (DCPH:NSQ) traded at 14.23, -19.74% below its 52-week high of 17.73, set on Mar 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | -- |
Low | -- |
Bid | 13.61 |
Offer | 14.72 |
Previous close | 14.23 |
Average volume | 440.91k |
---|---|
Shares outstanding | 80.80m |
Free float | 56.16m |
P/E (TTM) | -- |
Market cap | 1.15bn USD |
EPS (TTM) | -2.29 USD |
Data delayed at least 15 minutes, as of Apr 18 2024 21:00 BST.
More ▼